| An overview of antibody conjugated polymeric nanoparticles for breast cancer therapy A Juan, FJ Cimas, I Bravo, A Pandiella, A Ocaña, C Alonso-Moreno Pharmaceutics 12 (9), 802, 2020 | 97 | 2020 |
| Antibody conjugation of nanoparticles as therapeutics for breast cancer treatment A Juan, FJ Cimas, I Bravo, A Pandiella, A Ocaña, C Alonso-Moreno International journal of molecular sciences 21 (17), 6018, 2020 | 83 | 2020 |
| Controlled delivery of BET-PROTACs: in vitro evaluation of MZ1-loaded polymeric antibody conjugated nanoparticles in breast cancer FJ Cimas, E Niza, A Juan, MM Noblejas-López, I Bravo, A Lara-Sanchez, ... Pharmaceutics 12 (10), 986, 2020 | 52 | 2020 |
| ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma L Arias-González, I Moreno-Gimeno, AR del Campo, SO Leticia, ... Neoplasia 15 (6), 649-IN17, 2013 | 52 | 2013 |
| Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance J García-Cano, G Ambroise, R Pascual-Serra, MC Carrión, ... Oncotarget 6 (17), 15551, 2015 | 50 | 2015 |
| p38MAPK and chemotherapy: we always need to hear both sides of the story J García-Cano, O Roche, FJ Cimas, R Pascual-Serra, M Ortega-Muelas, ... Frontiers in cell and developmental biology 4, 69, 2016 | 49 | 2016 |
| Noncanonical TGFβ pathway relieves the blockade of IL1β/TGFβ-mediated crosstalk between tumor and stroma: TGFBR1 and TAK1 inhibition in colorectal cancer N Guillen Diaz-Maroto, R Sanz-Pamplona, M Berdiel-Acer, FJ Cimas, ... Clinical Cancer Research 25 (14), 4466-4479, 2019 | 39 | 2019 |
| Abrogation of the p38 MAPK α signaling pathway does not promote radioresistance but its activity is required for 5-Fluorouracil-associated radiosensitivity MA de la Cruz-Morcillo, J García-Cano, L Arias-González, E García-Gil, ... Cancer letters 335 (1), 66-74, 2013 | 36 | 2013 |
| Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion L Serrano-Oviedo, M Ortega-Muelas, J Garcia-Cano, ML Valero, ... PLoS One 13 (7), e0200878, 2018 | 30 | 2018 |
| Genomic mapping identifies mutations in RYR2 and AHNAK as associated with favorable outcome in basal-like breast tumors expressing PD1/PD-L1 FJ Cimas, A Manzano, M Baliu-Piqué, E García-Gil, P Pérez-Segura, ... Cancers 12 (8), 2243, 2020 | 26 | 2020 |
| Genomic signatures of immune activation predict outcome in advanced stages of ovarian cancer and basal-like breast tumors A Alcaraz-Sanabria, M Baliu-Piqué, C Saiz-Ladera, K Rojas, A Manzano, ... Frontiers in Oncology 9, 1486, 2020 | 24 | 2020 |
| In silico transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer K Rojas, M Baliu-Piqué, A Manzano, C Saiz-Ladera, V García-Barberán, ... Cellular Oncology 44, 569-580, 2021 | 19 | 2021 |
| The gene signature of activated M-CSF-primed human monocyte-derived macrophages is IL-10-dependent VD Cuevas, M Simón-Fuentes, E Orta-Zavalza, R Samaniego, ... Journal of Innate Immunity 14 (3), 243-256, 2022 | 18 | 2022 |
| E1a is an exogenous in vivo tumour suppressor FJ Cimas, JL Callejas-Valera, DC García-Olmo, J Hernández-Losa, ... Cancer Letters 399, 74-81, 2017 | 15 | 2017 |
| E1a promotes c-Myc-dependent replicative stress: implications in glioblastoma radiosensitization ML Valero, FJ Cimas, L Arias, P Melgar-Rojas, E García, ... Cell Cycle 13 (1), 52-61, 2014 | 15 | 2014 |
| The Pseudokinase TRIB3 negatively regulates the HER2 receptor pathway and is a biomarker of good prognosis in luminal breast cancer A Orea-Soufi, S Castillo-Lluva, N Salvador-Tormo, P Martín-Cabrera, ... Cancers 13 (21), 5307, 2021 | 13 | 2021 |
| Implication of VHL, ERK5, and HIF-1alpha in clear cell renal cell carcinoma: Molecular basis L Serrano-Oviedo, JM Giménez-Bachs, SY Nam-Cha, FJ Cimas, ... Urologic Oncology: Seminars and Original Investigations 35 (3), 114. e15-114 …, 2017 | 13 | 2017 |
| MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells FJ Cimas, JL Callejas-Valera, R Pascual-Serra, J García-Cano, ... Oncotarget 6 (42), 44095, 2015 | 13 | 2015 |
| Hepatitis C virus RNA-Dependent RNA polymerase interacts with the Akt/PKB kinase and induces its subcellular relocalization ML Valero, R Sabariegos, FJ Cimas, C Perales, E Domingo, ... Antimicrobial Agents and Chemotherapy 60 (6), 3540-3550, 2016 | 9 | 2016 |
| TRIB1 regulates tumor growth via controlling tumor-associated macrophage phenotypes and is associated with breast cancer survival and treatment response T Kim, J Johnston, S Castillo-Lluva, FJ Cimas, S Hamby, TC Consortium, ... Theranostics 12 (8), 3584, 2022 | 8 | 2022 |
